tiprankstipranks
Danaher Corporation (DHR)
NYSE:DHR
US Market
Want to see DHR full AI Analyst Report?

Danaher (DHR) Stock Forecast & Price Target

3,249 Followers
See the Price Targets and Ratings of:

DHR Analyst Ratings

Strong Buy
18Ratings
Strong Buy
16 Buy
2 Hold
0 Sell
Based on 18 analysts giving stock ratings to
Danaher
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

DHR Stock 12 Month Forecast

Average Price Target

$237.71
▲(22.06% Upside)
Based on 18 Wall Street analysts offering 12 month price targets for Danaher in the last 3 months. The average price target is $237.71 with a high forecast of $270.00 and a low forecast of $184.04. The average price target represents a 22.06% change from the last price of $194.75.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"183":"$183","205":"$205","227":"$227","249":"$249","271":"$271"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":270,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$270.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":237.70823529411766,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$237.71</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":184.04,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$184.04</span>\n  </div></div>","useHTML":true}}],"tickPositions":[183,205,227,249,271],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Jul<br/>2025","6":"Oct<br/>2025","9":"Jan<br/>2026","12":"Apr<br/>2026","25":"Apr<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,190.79,196.8830769230769,202.97615384615384,209.06923076923076,215.16230769230768,221.2553846153846,227.34846153846155,233.44153846153847,239.5346153846154,245.6276923076923,251.72076923076924,257.81384615384616,263.9069230769231,{"y":270,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,190.79,194.39909502262444,198.00819004524885,201.6172850678733,205.22638009049774,208.8354751131222,212.4445701357466,216.05366515837105,219.66276018099546,223.2718552036199,226.88095022624435,230.4900452488688,234.0991402714932,{"y":237.70823529411766,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,190.79,190.27076923076922,189.75153846153844,189.23230769230767,188.71307692307693,188.19384615384615,187.67461538461538,187.1553846153846,186.63615384615383,186.11692307692306,185.5976923076923,185.07846153846154,184.55923076923077,{"y":184.04,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":199.018,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 30,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":195.363,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 27,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":187.934,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 28,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":200.041,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 26,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":196.052,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 25,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":204.736,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 21,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":212.133,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":214.624,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":223.354,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 20,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":228.433,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 28,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":222.944,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 33,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":205.561,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 27,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":190.79,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 26,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target$270.00Average Price Target$237.71Lowest Price Target$184.04
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Argus Research Analyst forecast on DHR
Argus Research
Argus Research
$265$230
Buy
18.10%
Upside
Assigned
04/23/26
Analysts Offer Insights on Healthcare Companies: Danaher (NYSE: DHR), Thermo Fisher (NYSE: TMO) and Biogen (NASDAQ: BIIB)
Morgan Stanley Analyst forecast on DHR
Morgan Stanley
Morgan Stanley
$255$184.04
Buy
-5.50%
Downside
Assigned
04/23/26
Morgan Stanley Sticks to Its Buy Rating for Danaher (DHR)
Wells Fargo
$240$212
Hold
8.86%
Upside
Assigned
04/22/26
Analysts Have Conflicting Sentiments on These Healthcare Companies: Beta Bionics, Inc. (NASDAQ: BBNX), Danaher (NYSE: DHR) and Tango Therapeutics (NASDAQ: TNGX)
Robert W. Baird
$249$245
Buy
25.80%
Upside
Reiterated
04/22/26
Danaher price target lowered to $245 from $249 at BairdDanaher price target lowered to $245 from $249 at Baird
Jefferies
$245
Buy
25.80%
Upside
Reiterated
04/22/26
Danaher price target raised to $245 from $240 at JefferiesDanaher price target raised to $245 from $240 at Jefferies
UBS
$270$250
Buy
28.37%
Upside
Reiterated
04/22/26
Danaher price target lowered to $250 from $270 at UBSDanaher price target lowered to $250 from $270 at UBS
Stifel Nicolaus Analyst forecast on DHR
Stifel Nicolaus
Stifel Nicolaus
$260
Buy
33.50%
Upside
Reiterated
04/22/26
Analysts Offer Insights on Healthcare Companies: Rapport Therapeutics, Inc. (NASDAQ: RAPP), Pyxis Oncology (NASDAQ: PYXS) and Danaher (NYSE: DHR)
William Blair Analyst forecast on DHR
William Blair
William Blair
Buy
Reiterated
04/22/26
Analysts Offer Insights on Healthcare Companies: Beta Bionics, Inc. (NASDAQ: BBNX), Danaher (NYSE: DHR) and Vertex Pharmaceuticals (NASDAQ: VRTX)
J.P. Morgan Analyst forecast on DHR
J.P. Morgan
J.P. Morgan
$275$245
Buy
25.80%
Upside
Reiterated
04/22/26
Analysts Offer Insights on Healthcare Companies: Rapport Therapeutics, Inc. (NASDAQ: RAPP), Danaher (NYSE: DHR) and Intuitive Surgical (NASDAQ: ISRG)
Barclays Analyst forecast on DHR
Barclays
Barclays
$230
Buy
18.10%
Upside
Assigned
04/22/26
Wall Street Analysts Are Bullish on Top Healthcare Picks
TD Cowen
$245$240
Buy
23.23%
Upside
Assigned
04/21/26
Analysts' Opinions Are Mixed on These Healthcare Stocks: Beta Bionics, Inc. (NASDAQ: BBNX) and Danaher (NYSE: DHR)
Guggenheim Analyst forecast on DHR
Guggenheim
Guggenheim
$275$235
Buy
20.67%
Upside
Reiterated
04/21/26
Guggenheim Reaffirms Their Buy Rating on Danaher (DHR)
Bank of America Securities Analyst forecast on DHR
Bank of America Securities
Bank of America Securities
$270
Buy
38.64%
Upside
Reiterated
04/21/26
Analysts Offer Insights on Healthcare Companies: Danaher (NYSE: DHR), Hims & Hers Health (NYSE: HIMS) and UnitedHealth (NYSE: UNH)
Evercore ISI Analyst forecast on DHR
Evercore ISI
Evercore ISI
$225
Buy
15.53%
Upside
Reiterated
04/21/26
Analysts Conflicted on These Healthcare Names: AbbVie (NYSE: ABBV) and Danaher (NYSE: DHR)
Goldman Sachs Analyst forecast on DHR
Goldman Sachs
Goldman Sachs
$230
Buy
18.10%
Upside
Reiterated
04/21/26
Analysts Offer Insights on Healthcare Companies: Rapport Therapeutics, Inc. (NASDAQ: RAPP), CareCloud (NASDAQ: CCLD) and Danaher (NYSE: DHR)
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Argus Research Analyst forecast on DHR
Argus Research
Argus Research
$265$230
Buy
18.10%
Upside
Assigned
04/23/26
Analysts Offer Insights on Healthcare Companies: Danaher (NYSE: DHR), Thermo Fisher (NYSE: TMO) and Biogen (NASDAQ: BIIB)
Morgan Stanley Analyst forecast on DHR
Morgan Stanley
Morgan Stanley
$255$184.04
Buy
-5.50%
Downside
Assigned
04/23/26
Morgan Stanley Sticks to Its Buy Rating for Danaher (DHR)
Wells Fargo
$240$212
Hold
8.86%
Upside
Assigned
04/22/26
Analysts Have Conflicting Sentiments on These Healthcare Companies: Beta Bionics, Inc. (NASDAQ: BBNX), Danaher (NYSE: DHR) and Tango Therapeutics (NASDAQ: TNGX)
Robert W. Baird
$249$245
Buy
25.80%
Upside
Reiterated
04/22/26
Danaher price target lowered to $245 from $249 at BairdDanaher price target lowered to $245 from $249 at Baird
Jefferies
$245
Buy
25.80%
Upside
Reiterated
04/22/26
Danaher price target raised to $245 from $240 at JefferiesDanaher price target raised to $245 from $240 at Jefferies
UBS
$270$250
Buy
28.37%
Upside
Reiterated
04/22/26
Danaher price target lowered to $250 from $270 at UBSDanaher price target lowered to $250 from $270 at UBS
Stifel Nicolaus Analyst forecast on DHR
Stifel Nicolaus
Stifel Nicolaus
$260
Buy
33.50%
Upside
Reiterated
04/22/26
Analysts Offer Insights on Healthcare Companies: Rapport Therapeutics, Inc. (NASDAQ: RAPP), Pyxis Oncology (NASDAQ: PYXS) and Danaher (NYSE: DHR)
William Blair Analyst forecast on DHR
William Blair
William Blair
Buy
Reiterated
04/22/26
Analysts Offer Insights on Healthcare Companies: Beta Bionics, Inc. (NASDAQ: BBNX), Danaher (NYSE: DHR) and Vertex Pharmaceuticals (NASDAQ: VRTX)
J.P. Morgan Analyst forecast on DHR
J.P. Morgan
J.P. Morgan
$275$245
Buy
25.80%
Upside
Reiterated
04/22/26
Analysts Offer Insights on Healthcare Companies: Rapport Therapeutics, Inc. (NASDAQ: RAPP), Danaher (NYSE: DHR) and Intuitive Surgical (NASDAQ: ISRG)
Barclays Analyst forecast on DHR
Barclays
Barclays
$230
Buy
18.10%
Upside
Assigned
04/22/26
Wall Street Analysts Are Bullish on Top Healthcare Picks
TD Cowen
$245$240
Buy
23.23%
Upside
Assigned
04/21/26
Analysts' Opinions Are Mixed on These Healthcare Stocks: Beta Bionics, Inc. (NASDAQ: BBNX) and Danaher (NYSE: DHR)
Guggenheim Analyst forecast on DHR
Guggenheim
Guggenheim
$275$235
Buy
20.67%
Upside
Reiterated
04/21/26
Guggenheim Reaffirms Their Buy Rating on Danaher (DHR)
Bank of America Securities Analyst forecast on DHR
Bank of America Securities
Bank of America Securities
$270
Buy
38.64%
Upside
Reiterated
04/21/26
Analysts Offer Insights on Healthcare Companies: Danaher (NYSE: DHR), Hims & Hers Health (NYSE: HIMS) and UnitedHealth (NYSE: UNH)
Evercore ISI Analyst forecast on DHR
Evercore ISI
Evercore ISI
$225
Buy
15.53%
Upside
Reiterated
04/21/26
Analysts Conflicted on These Healthcare Names: AbbVie (NYSE: ABBV) and Danaher (NYSE: DHR)
Goldman Sachs Analyst forecast on DHR
Goldman Sachs
Goldman Sachs
$230
Buy
18.10%
Upside
Reiterated
04/21/26
Analysts Offer Insights on Healthcare Companies: Rapport Therapeutics, Inc. (NASDAQ: RAPP), CareCloud (NASDAQ: CCLD) and Danaher (NYSE: DHR)
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Danaher

3 Months
xxx
Success Rate
8/13 ratings generated profit
62%
Average Return
+0.70%
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 61.54% of your transactions generating a profit, with an average return of +0.70% per trade.
1 Year
Success Rate
11/20 ratings generated profit
55%
Average Return
+6.19%
Copying Patrick B Donnelly's trades and holding each position for 1 Year would result in 55.00% of your transactions generating a profit, with an average return of +6.19% per trade.
2 Years
xxx
Success Rate
7/20 ratings generated profit
35%
Average Return
-0.73%
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 35.00% of your transactions generating a profit, with an average return of -0.73% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

DHR Analyst Recommendation Trends

Rating
Dec 25
Jan 26
Feb 26
Mar 26
Apr 26
Strong Buy
0
0
0
0
0
Buy
20
28
33
27
26
Hold
4
1
1
0
2
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
24
29
34
27
28
In the current month, DHR has received 26 Buy Ratings, 2 Hold Ratings, and 0 Sell Ratings. DHR average Analyst price target in the past 3 months is 237.71.
Each month's total comprises the sum of three months' worth of ratings.

DHR Financial Forecast

DHR Earnings Forecast

Next quarter’s earnings estimate for DHR is $1.83 with a range of $1.81 to $1.87. The previous quarter’s EPS was $2.06. DHR beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year DHR has Performed in-line its overall industry.
Next quarter’s earnings estimate for DHR is $1.83 with a range of $1.81 to $1.87. The previous quarter’s EPS was $2.06. DHR beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year DHR has Performed in-line its overall industry.

DHR Sales Forecast

Next quarter’s sales forecast for DHR is $6.09B with a range of $6.08B to $6.13B. The previous quarter’s sales results were $5.95B. DHR beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year DHR has Performed in-line its overall industry.
Next quarter’s sales forecast for DHR is $6.09B with a range of $6.08B to $6.13B. The previous quarter’s sales results were $5.95B. DHR beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year DHR has Performed in-line its overall industry.

DHR Stock Forecast FAQ

What is DHR’s average 12-month price target, according to analysts?
Based on analyst ratings, Danaher Corporation’s 12-month average price target is 237.71.
    What is DHR’s upside potential, based on the analysts’ average price target?
    Danaher Corporation has 22.06% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is DHR a Buy, Sell or Hold?
          Danaher Corporation has a consensus rating of Strong Buy which is based on 16 buy ratings, 2 hold ratings and 0 sell ratings.
            What is Danaher Corporation’s price target?
            The average price target for Danaher Corporation is 237.71. This is based on 18 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst price target is $270.00 ,the lowest forecast is $184.04. The average price target represents 22.06% Increase from the current price of $194.75.
              What do analysts say about Danaher Corporation?
              Danaher Corporation’s analyst rating consensus is a Strong Buy. This is based on the ratings of 18 Wall Streets Analysts.
                How can I buy shares of DHR?
                Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.